T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRE
1676
DELISTED
Veris Residential
VRE
| $931K | ﹤0.01% |
42,434
| – | – |
|
|
ACAS
1677
DELISTED
American Capital Ltd
ACAS
| $931K | ﹤0.01% |
67,680
| – | – |
|
|
BRS
1678
DELISTED
Bristow Group, Inc.
BRS
| $930K | ﹤0.01% |
12,780
+1,100
| +9% | +$75.6K |
|
1679
Fair Isaac
FICO
$22.8B
| $922K | ﹤0.01% |
16,681
+300
| +2% | +$15.4K |
|
1680
HEICO Corp
HEI
$51.3B
| $921K | ﹤0.01% |
41,498
| – | – |
|
|
S
1681
DELISTED
Sprint Corporation
S
| $920K | ﹤0.01% |
+148,185
| New | +$975K |
|
1682
Korn Ferry
KFY
$4.26B
| $916K | ﹤0.01% |
42,800
-869,900
| -95% | -$17.2M |
|
|
HME
1683
DELISTED
HOME PROPERTIES, INC
HME
| $912K | ﹤0.01% |
15,790
+800
| +5% | +$49.1K |
|
1684
World Kinect Corp
WKC
$1.91B
| $907K | ﹤0.01% |
24,300
| – | – |
|
1685
Avista
AVA
$3.25B
| $903K | ﹤0.01% |
34,190
+2,100
| +7% | +$57.5K |
|
|
BMR
1686
DELISTED
BIOMED REALTY TRUST INC
BMR
| $900K | ﹤0.01% |
48,400
+7,700
| +19% | +$151K |
|
1687
Helix Energy Solutions
HLX
$1.5B
| $896K | ﹤0.01% |
35,317
| – | – |
|
|
CVG
1688
DELISTED
Convergys
CVG
| $883K | ﹤0.01% |
47,100
-5,000
| -10% | -$93.7K |
|
1689
Leidos
LDOS
$17.7B
| $879K | ﹤0.01% |
19,300
-148,261
| -88% | -$5.51M |
|
1690
KB Home
KBH
$3.45B
| $878K | ﹤0.01% |
48,700
+15,300
| +46% | +$268K |
|
|
HTD
1691
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$902M
| $870K | ﹤0.01% |
50,000
| – | – |
|
1692
Hancock Whitney
HWC
$6.35B
| $868K | ﹤0.01% |
27,660
| – | – |
|
|
CIM
1693
Chimera Investment
CIM
$1B
| $864K | ﹤0.01% |
18,940
| – | – |
|
1694
Targa Resources
TRGP
$57.9B
| $861K | ﹤0.01% |
11,800
-263,447
| -96% | -$18.2M |
|
1695
CACI
CACI
$14.9B
| $857K | ﹤0.01% |
12,400
+1,300
| +12% | +$86.8K |
|
1696
Group 1 Automotive
GPI
$3.11B
| $854K | ﹤0.01% |
11,000
| – | – |
|
1697
Curtiss-Wright
CW
$25.7B
| $850K | ﹤0.01% |
18,100
| – | – |
|
1698
Halozyme
HALO
$11.4B
| $849K | ﹤0.01% |
76,900
+7,800
| +11% | +$65K |
|
1699
Avient
AVNT
$4.2B
| $845K | ﹤0.01% |
27,530
+4,200
| +18% | +$119K |
|
1700
Wendy's
WEN
$1.64B
| $845K | ﹤0.01% |
99,615
-10,600
| -10% | -$79.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.